PPARG and malignant colon neoplasm: In gastric and colon cancer cells, PPARγ decreases β-catenin expression, subcellular localization, and downstream effectors, resulting in the modulation of several genes, such as telomerase reverse transcriptase, and Sox9, which are involved in cell development, differentiation, and survival processes (105–107).